58588 Federal Register / Vol. 88, No. 165 / Monday, August 28, 2023 / Notices 

SUMMARY: In accordance with regulatory 

provisions, the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting for the 

Subcommittee on Procedures Reviews 

(SPR) of the Advisory Board on 

Radiation and Worker Health (ABRWH 

or the Advisory Board). This meeting is 

open to the public, but without a public 

comment period. The public is welcome 

to submit written comments in advance 

of the meeting, to the contact person 

below. Written comments received in 

advance of the meeting will be included 

in the official record of the meeting. The 

public is also welcomed to listen to the 

meeting by joining the audio conference 

(information below). The audio 

conference line has 150 ports for callers. 

DATES: The meeting will be held on 

November 16, 2023, from 11 a.m. to 4:30 

p.m., EST. Written comments must be 

received on or before November 9, 2023. 

ADDRESSES: You may submit comments 

by mail to: Rashaun Roberts, National 

Institute for Occupational Safety and 

Health Centers for Disease Control and 

Prevention, 1090 Tusculum Avenue, MS 

C–24, Cincinnati, Ohio 45226. 

Meeting Information: Audio 

Conference Call via FTS Conferencing. 

The USA toll-free dial-in number is 1– 

866–659–0537; the pass code is 

9933701. 

FOR FURTHER INFORMATION CONTACT: 

Rashaun Roberts, Ph.D., Designated 

Federal Officer, National Institute for 

Occupational Safety and Health, Centers 

for Disease Control and Prevention, 

1090 Tusculum Avenue, MS C–24, 

Cincinnati, Ohio 45226. Telephone: 

(513) 533–6800; Email: ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board on 

Radiation and Worker Health (ABRWH 

or the Advisory Board) was established 

under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that 

have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule; advice on 

methods of dose reconstruction, which 

have also been promulgated by HHS as 

a final rule; advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program; and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort. In December 

2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, 

which subsequently delegated this 

authority to the Centers for Disease 

Control and Prevention (CDC). The 

National Institute for Occupational 

Safety and Health (NIOSH) implements 

this responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

and rechartered under Executive Order 

13889 on March 22, 2022, and will 

terminate on March 22, 2024. 

Purpose: The Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary 

on whether there is a class of employees 

at any Department of Energy facility 

who were exposed to radiation but for 

whom it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. The 

ABRWH Subcommittee on Procedures 

Reviews (SPR) is responsible for 

overseeing, tracking, and participating 

in the reviews of all procedures used in 

the dose reconstruction process by the 

NIOSH Division of Compensation 

Analysis and Support (DCAS) and its 

dose reconstruction contractor (Oak 

Ridge Associated Universities—ORAU). 

Matters to be Considered: The agenda 

will include discussions on the 

following: 1. Carry-over items from June 

21, 2023, SPR Meeting including a. 

Sandford Cohen & Associates (SC&A) 

follow-up review of PER–049 (Paducah 

Gaseous Diffusion Plant) internal dose 

assessment using hypothetical intakes 

versus bioassay data and b. SC&A’s Peek 

Street memo on the review of two 

additional cases provided by NIOSH; 2. 

Newly issued SC&A reviews including 

a. DCAS–PER–040 ‘‘Mallinckrodt TBD 

Revisions,’’ b. DCAS–PER–051 ‘‘Weldon 

Spring Plant,’’ c. DCAS–PER–083 

‘‘Weldon Spring Plant TBD Revision,’’ 

d. DCAS–PER–067 ‘‘Allegheny Ludlum 

Appendix Q Revisions,’’ and e. 

ORAUT–RPRT–0097 ‘‘Breathing Zone to 

General Area Air Concentration Ratios 

in Small Workrooms’’; 3. Preparation for 

the December 2023 Full ABRWH 

Meeting: Review of SPR 

accomplishments and current activities; 

4. Preparation for the April 2024 Full 

ABRWH Meeting: Review of technical 

guidance documents ready for full 

Board approval; and 5. Newly Issued 

Guidance and Supplemental Topics. 

Agenda items are subject to change as 

priorities dictate. For additional 

information, please contact Toll Free 

1(800) 232–4636. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–18452 Filed 8–25–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10553, CMS– 

10554, CMS–10856 and CMS–R–305] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 165 / Monday, August 28, 2023 / Notices 58589 

DATES: Comments must be received by 

October 27, 2023. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number: ll, Room C4–26–05, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10553 Medicaid Managed Care 

Quality including Supporting 

Regulations. 

CMS–10554 Children’s Health 

Insurance Program Managed Care 

and Supporting Regulations. 

CMS–10856 Medicaid Managed Care 

and Supporting Regulations. 

CMS–R–305 External Quality Review 

(EQR) of Medicaid and Children’s 

Health Insurance Program (CHIP) 

Managed Care, EQR Protocols, and 

Supporting Regulations. 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Medicaid 

Managed Care Quality including 

Supporting Regulations; Use: States are 

required to develop quality strategies 

and quality strategy effectiveness 

evaluations. States use the information 

from these documents to help monitor 

and assess the performance of their 

Medicaid managed care programs. 

When developing these documents, 

States must engage stakeholders and 

make the documents available for public 

comment. Medicaid beneficiaries and 

stakeholders use the reported 

information to understand the state’s 

quality improvement goals and 

objectives, and to understand how the 

state is measuring progress of its goals. 

States must submit these documents to 

CMS for review at least once every three 

years, or when substantial changes are 

made to their quality strategies, or State 

Medicaid programs. CMS uses this 

information as a part of its oversight 

responsibilities. The Medicaid and CHIP 

(MAC) QRS requirements currently 

include public posting of quality ratings 

on the State’s website, which is 

intended to provide beneficiaries and 

their caregivers with a web-based 

interface to compare Medicaid and CHIP 

managed care plans based on assigned 

ratings. Form Number: CMS–10553 

(OMB control number: 0938–1281); 

Frequency: Annually, triennial, and 

one-time.; Affected Public: Private 

sector (business or other for-profits) and 

State, local or Tribal governments; 

Number of Respondents: 673; Number 

of Responses: 6,087; Total Annual 

Hours: 1,441,211. (For policy questions 

regarding this collection contact Carlye 

Burd at 720–853–2780.) 

2. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Children’s 

Health Insurance Program Managed 

Care and Supporting Regulations; Use: 

States must provide information 

obtained through methods consistent 

with the Protocols specified by CMS to 

External Quality Review Organization 

(EQRO). States must post the EQR 

technical reports on their websites to 

help enrollees and potential enrollees 

make informed choices when selecting 

providers. It also gives advocacy 

organizations, researchers, and other 

interested parties access to information 

pertaining to: the quality of care 

provided to beneficiaries enrolled in 

CHIP managed care organizations 

(MCO), prepaid inpatient health plans 

(PIHP), and prepaid ambulatory health 

plans (PAHP). The quality ratings 

system (QRS) provides beneficiaries 

with information that allows them to 

make an informed choice when 

comparing and selecting managed care 

plans. The information also provides a 

better understanding of the state’s 

quality improvement goals and 

objectives, and how the state is 

measuring the progress of its goals. The 

information may assist states in 

comparing the outcomes of different 

delivery systems and can assist them in 

identifying future performance 

improvement subjects. Form Number: 

CMS–10554 (OMB control number: 

0938–1282); Frequency: Annually and 

one-time; Affected Public: Private sector 

(business or other for-profits and notfor-profit institutions) and State, local, 

and Tribal governments; Number of 

Respondents: 62; Number of Responses: 

2,735,906; Total Annual Hours: 365,310. 

(For policy questions regarding this 

collection contact Joshua Bougie at 410– 

786–8117.) 

3. Type of Information Collection 

Request: New; Title of Information 

Collection: Medicaid Managed Care and 

Supporting Regulations; Use: Provides 

reporting and third-party disclosure 

requirements pertaining to State 

program administration and CMS 

compliance monitoring. Form Number: 

CMS–10856 (OMB control number: 

0938–TBD); Frequency: Annually and 

one-time; Affected Public: Private sector 

(business or other for-profits) and State, 

local or Tribal governments; Number of 

Respondents: 679; Number of 

Responses: 14,313; Total Annual Hours: 

255,384. (For policy questions regarding 

this collection contact Amy Gentile at 

410–786–3499.) 

4. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: External Quality 

Review (EQR) of Medicaid and 

Children’s Health Insurance Program 

(CHIP) Managed Care, EQR Protocols, 

and Supporting Regulations; Use: Most 

contracts between a state Medicaid 

agency and their managed care plan 


lotter on DSK11XQN23PROD with NOTICES1
58590 Federal Register / Vol. 88, No. 165 / Monday, August 28, 2023 / Notices 

must provide for an annual External 

Quality Review (EQR). The annual EQR 

is conducted by an independent 

external quality review organization 

(EQRO). States must provide the EQRO 

with information obtained through 

methods consistent with the protocols 

specified by CMS. The information is 

used by the EQRO to determine the 

quality of care furnished by the 

managed care plans in the state. The 

publicly posted EQR results allows 

Medicaid/CHIP enrollees and potential 

enrollees to make informed choices 

regarding the selection of their 

providers. It also provides advocacy 

organizations, researchers, and other 

interested parties access to information 

on the quality of care provided to 

Medicaid beneficiaries enrolled in 

Medicaid/CHIP managed care. States 

use the information during their 

oversight of these organizations. Form 

Number: CMS–R–305 (OMB control 

number: 0938–0786); Frequency: 

Annually and one-time; Affected Public: 

Private sector (business or other forprofits) and State, local or Tribal 

governments; Number of Respondents: 

698; Number of Responses: 10,249; 

Total Annual Hours: 483,784. (For 

policy questions regarding this 

collection contact Carlye Burd at 720– 

853–2780.) 

Dated: August 23, 2023. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2023–18520 Filed 8–25–23; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Special 

Emphasis Panel; NCATS SBIR Basket 

Clinical Trials. 

Date: September 21, 2023. 

Time: 11:30 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Center for Advancing Translational 

Sciences, 6701 Democracy Boulevard, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Nakia C Brown, Ph.D., 

Scientific Review Officer, Office of Grants 

Management and Scientific Review, National 

Center for Advancing Translational Sciences, 

National Institutes of Health, 6701 

Democracy Boulevard, Room 1037, Bethesda, 

MD 20892, (301) 827–3484, brownnac@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: August 23, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–18490 Filed 8–25–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The invention listed below is 

owned by an agency of the U.S. 

Government and is available for 

licensing to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. 

FOR FURTHER INFORMATION CONTACT: 

Licensing information may be obtained 

by communicating with Vidita 

Choudhry, Ph.D., Office of Technology 

Transfer and Development, National 

Heart, Lung, and Blood Institute, 31 

Center Drive Room 4A29, MSC2479, 

Bethesda, MD 20892–2479; telephone: 

301–594–4095; email: vidita.choudhry@

nih.gov. A signed Confidential 

Disclosure Agreement may be required 

to receive any unpublished information. 

SUPPLEMENTARY INFORMATION: 

Technology description follows. 

Apparatus for Cryogenic-Electron 

Microscopy Sample Preparation 

Cryo-Electron Microscopy (cryo-EM) 

is used to obtain high-resolution 

structural images of macromolecular 

structures. Samples must be purified 

and loaded onto cryo-EM grids before 

imaging. The ideal cryo-EM grid 

consists of particles that are evenly and 

richly distributed in a broad distribution 

of orientations throughout the holes of 

the support film. Current techniques to 

prepare cryo-EM grids are performed 

manually and require trial and error, 

resulting in a bottleneck in cryo-EM 

workflows. 

Researchers have developed a device 

and method for time-resolved 

preparation of liquid samples for cryoEM experiments. In particular, the 

mixing and dispensation of liquid 

samples is achieved by electrical signals 

that are transduced into specific 

acoustic frequencies to mix the liquid 

samples (low frequency) and then 

dispense the mixture (high frequency) 

in small, nanoliter volumes onto a cryoEM grid. This novel apparatus and 

method provides more precise control 

over liquid sample mixing and 

dispensing, and improved dispensation 

of the mixture onto the EM grid. Also, 

the improved quality of captured images 

of homogeneous macromolecular 

structures is achieved due to a 

uniformly mixed and dispensed sample 

on the EM grid. This allows electrons to 

be transmitted through the very thin 

liquid film in the holes of the cryo-EM 

grid to form an image. 

Potential Commercial Applications 

• Automation of cryo-EM 

experiments aimed at Structure-based 

Drug Design by examining 

macromolecular structure and its 

interactions with ligands. 

• Kits with hardware and software 

components to setup robotic automation 

of cryo-EM sample preparation, 

dispensation, plunging and storage. 

Competitive Advantages 

• Automated workflow eliminates the 

guesswork out of cryo-EM sample 

preparation. 

• Increases sample prep success rate 

and decreases the need to screen 

repeated trials. 

• Using acoustic-based, multiplesample mixing enables homogeneous 

mixing and facilitates the observation of 

transient molecular interactions with 

high time resolution. 

• Python code is available for 

command and control of a robot that 

manipulates the cryo-EM grid. 


lotter on DSK11XQN23PROD with NOTICES1